On Monday, shares of Ocular Therapeutix Inc (NASDAQ:OCUL), subtract -6.78% and shut at $10.17 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $9.51 and $11.50. Ocular Therapeutix, Inc. (OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, recently declared positive topline results from its phase 3 clinical trial of DEXTENZA™ (dexamethasone insert) 0.4 mg, for the treatment of post-surgical ocular inflammation and pain. DEXTENZA is a product candidate administered by a physician as a bioresorbable intracanalicular insert and designed for drug release to the ocular surface for up to 30 days.
The trial successfully met its two primary efficacy endpoints for inflammation and pain, achieving statistically noteworthydifferences between the treatment group and the placebo group for the absence of inflammatory cells on day 14 and the absence of pain on day 8, respectively. 52.3%% of patients treated with DEXTENZA showed an absence of inflammatory cells in the anterior chamber of the study eye on day 14, contrast to 31.1% of those receiving the placebo vehicle control punctum plug (p< 0.0001). 79.6% of patients treated with DEXTENZA stated absence of pain in the study eye on day 8, contrast to 61.3% of those receiving the placebo vehicle control punctum plug (p< 0.0001). For clarification of the endpoints, the day of surgery and insertion of DEXTENZA or the placebo is considered to be day 1.
Shares of Mastercard Inc (NYSE:MA), added 1.11% and shut at $105.94 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $104.69 and $106.00. The association’s commercial center capitalization is $115.80 Billion with the general uncommon loads of 1.07 billion. Cubic Transportation Systems (CTS), a business unit of Cubic Corporation (NYSE:CUB), and Mastercard (MA) recently declared the publication of their report about transportation demand and retail impact assessment resulting from New York City’s “Car Free Day NYC” at the Smart City Expo World Congress, held in Barcelona from November 15 – 17. Cubic and Mastercard leveraged the Urbanomics Mobility Project, a Cubic-Mastercard co-developed data analysis toolset for fueling smarter and more inclusive cities, in undertaking their assessment based on public transportation data and insights derived from anonymized and aggregated transaction data.
Cubic’s Urban Insights group and Mastercard collaborated on a request from New York City Councilman Ydanis Rodriguez to measure the impact of Car Free Day NYC held in April. As the transportation committee chair of the city’s first Earth Day event, Councilman Rodriguez organized the program with a strong coalition of local support toward the aim of reducing single-occupancy vehicle use and stimulating dialogue around environmental issues.